PPD, Inc. was named “Best Contract Research Organization” at the 14th annual Vaccine Industry Excellence (ViE) Awards during the 2021 World Vaccine Congress. Accelerated Enrollment Solutions (AES), a business of PPD, received the honor of “highly commended” in the category of “Best Clinical Trial Network.”
“When it comes to helping customers develop safe and effective vaccines, our dedicated experts are passionate about bringing their expertise to advance vaccine development to help people the world over,” said William Sharbaugh, chief operating officer of PPD. “The global pandemic demonstrated that our investments in vaccine-research capabilities positioned PPD well to support the urgent need for COVID-19 vaccines. This prestigious recognition is a testament to the ingenuity, commitment and drive of our global employees to help our customers save lives and create a healthier future.”
PPD was recognized as the best CRO for its end-to-end suite of clinical development services in core therapeutic areas, including a unit dedicated solely to vaccines, and the introduction and extension of new services, including digital clinical trial solutions. PPD® Laboratories offers specialized vaccine capabilities and has worked with 13 vaccines approved by the U.S. Food and Drug Administration. With more than 25 years of government and commercial vaccine experience, PPD has local expertise across 90 countries on six continents.